Sophia Analysis by Chemotherapy (Ctx) Choice: A Phase Iii (P3) Study of Margetuximab (M) plus Ctx Versus Trastuzumab (T) plus Ctx in Patients (Pts) with Pretreated Her2+Metastatic (Met) Breast Cancer (Mbc).

AuthID
 P-00S-VCD
20
Author(s)
Escriva, S
·
Im, SA
·
Cardoso, F
·
Cortes, J
·
Curigliano, G
·
Pegram, MD
·
Levy, C
·
De laurentiis, M
·
Ferrero, JM
·
Bahadur, SW
·
Kim, SB
·
Petrakova, K
·
Riseberg, DA
·
Yardley, DA
·
Edlich, S
·
Hong, S
·
Rock, EP
·
Document Type
Abstract
Year published
2020
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 38, Issue: 15
Indexing
Wos®
Publication Identifiers
Wos: WOS:000560368300210
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service